A Phase I, Multicenter, Open-label Study of Oral ABL001 in Patients With Chronic Myelogenous Leukemia (CML) or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)

This trial is no longer accepting participants. To get information / assistance in finding a clinical trial that's right for you, please call Cancer AnswerLine at 800-865-1125.